Brief: Insilico Medicine Cayman Topco Says Co, Tenacia Biotechnology Expand Ai-Driven Cns Collaboration
26/03/2026 01:39
March 26 (Reuters) - Insilico Medicine Cayman TopCo 3696.HK: CO, TENACIA BIOTECHNOLOGY EXPAND AI-DRIVEN CNS COLLABORATION WITH ADDITIONAL DEAL VALUE UP TO $94.75 MILLION Further company coverage: 3696.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insilico Medicine Cayman TopCo
See all newsInSilico Medicine jumps on progress in testing of new weight-loss drug
Development Collaboration
InSilico jumps on collaboration to develop biological frontier foundation models
HK-listed InSilico Medicine climbs as chairman buys shares
Brief: Insilico Medicine Cayman Topco's Chair Purchases Aggregate 113,500 Shares In Sept 4-7